210 related articles for article (PubMed ID: 23555036)
1. Soluble and membrane-bound TGF-β-mediated regulation of intratumoral T cell differentiation and function in B-cell non-Hodgkin lymphoma.
Yang ZZ; Grote DM; Ziesmer SC; Xiu B; Yates NR; Secreto FJ; Hodge LS; Witzig TE; Novak AJ; Ansell SM
PLoS One; 2013; 8(3):e59456. PubMed ID: 23555036
[TBL] [Abstract][Full Text] [Related]
2. TGF-β upregulates CD70 expression and induces exhaustion of effector memory T cells in B-cell non-Hodgkin's lymphoma.
Yang ZZ; Grote DM; Xiu B; Ziesmer SC; Price-Troska TL; Hodge LS; Yates DM; Novak AJ; Ansell SM
Leukemia; 2014 Sep; 28(9):1872-84. PubMed ID: 24569779
[TBL] [Abstract][Full Text] [Related]
3. Malignant B cells skew the balance of regulatory T cells and TH17 cells in B-cell non-Hodgkin's lymphoma.
Yang ZZ; Novak AJ; Ziesmer SC; Witzig TE; Ansell SM
Cancer Res; 2009 Jul; 69(13):5522-30. PubMed ID: 19509224
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of angiogenic cytokines and their receptors in reactive benign lymph nodes and non-Hodgkin lymphoma.
Ho CL; Sheu LF; Li CY
Ann Diagn Pathol; 2003 Feb; 7(1):1-8. PubMed ID: 12616467
[TBL] [Abstract][Full Text] [Related]
5. Programmed death ligand 1 is expressed by non-hodgkin lymphomas and inhibits the activity of tumor-associated T cells.
Andorsky DJ; Yamada RE; Said J; Pinkus GS; Betting DJ; Timmerman JM
Clin Cancer Res; 2011 Jul; 17(13):4232-44. PubMed ID: 21540239
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma.
Yang ZZ; Novak AJ; Stenson MJ; Witzig TE; Ansell SM
Blood; 2006 May; 107(9):3639-46. PubMed ID: 16403912
[TBL] [Abstract][Full Text] [Related]
7. Aminobisphosphonates prevent the inhibitory effects exerted by lymph node stromal cells on anti-tumor Vδ 2 T lymphocytes in non-Hodgkin lymphomas.
Musso A; Catellani S; Canevali P; Tavella S; Venè R; Boero S; Pierri I; Gobbi M; Kunkl A; Ravetti JL; Zocchi MR; Poggi A
Haematologica; 2014 Jan; 99(1):131-9. PubMed ID: 24162786
[TBL] [Abstract][Full Text] [Related]
8. Malignant B cells induce the conversion of CD4+CD25- T cells to regulatory T cells in B-cell non-Hodgkin lymphoma.
Han Y; Wu J; Bi L; Xiong S; Gao S; Yin L; Jiang L; Chen C; Yu K; Zhang S
PLoS One; 2011; 6(12):e28649. PubMed ID: 22174855
[TBL] [Abstract][Full Text] [Related]
9. Role of tumor-derived transforming growth factor-beta1 (TGF-beta1) in site-dependent tumorigenicity of murine ascitic lymphosarcoma.
Thakur VS; Shankar B; Chatterjee S; Premachandran S; Sainis KB
Cancer Immunol Immunother; 2005 Sep; 54(9):837-47. PubMed ID: 15726358
[TBL] [Abstract][Full Text] [Related]
10. Regulatory B cells in anti-tumor immunity.
Zhang Y; Gallastegui N; Rosenblatt JD
Int Immunol; 2015 Oct; 27(10):521-30. PubMed ID: 25999597
[TBL] [Abstract][Full Text] [Related]
11. Novel B7-H4-mediated crosstalk between human non-Hodgkin lymphoma cells and tumor-associated macrophages leads to immune evasion via secretion of IL-6 and IL-10.
Che F; Heng X; Zhang H; Su Q; Zhang B; Chen Y; Zhang Z; Du Y; Wang L
Cancer Immunol Immunother; 2017 Jun; 66(6):717-729. PubMed ID: 28246881
[TBL] [Abstract][Full Text] [Related]
12. IL-12 inhibits the TGF-β-dependent T cell developmental programs and skews the TGF-β-induced differentiation into a Th1-like direction.
Prochazkova J; Pokorna K; Holan V
Immunobiology; 2012 Jan; 217(1):74-82. PubMed ID: 21903294
[TBL] [Abstract][Full Text] [Related]
13. Blockade of surface-bound TGF-β on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment.
Budhu S; Schaer DA; Li Y; Toledo-Crow R; Panageas K; Yang X; Zhong H; Houghton AN; Silverstein SC; Merghoub T; Wolchok JD
Sci Signal; 2017 Aug; 10(494):. PubMed ID: 28851824
[TBL] [Abstract][Full Text] [Related]
14. T-cell-mediated antitumor immunity in B-cell non-Hodgkin lymphoma: activation, suppression and exhaustion.
Yang ZZ; Liang AB; Ansell SM
Leuk Lymphoma; 2015; 56(9):2498-504. PubMed ID: 25651421
[TBL] [Abstract][Full Text] [Related]
15. TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma.
Josefsson SE; Beiske K; Blaker YN; Førsund MS; Holte H; Østenstad B; Kimby E; Köksal H; Wälchli S; Bai B; Smeland EB; Levy R; Kolstad A; Huse K; Myklebust JH
Cancer Immunol Res; 2019 Mar; 7(3):355-362. PubMed ID: 30659053
[TBL] [Abstract][Full Text] [Related]
16. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of antitumor-specific cytotoxic T lymphocytes from autologous tumor infiltrating lymphocytes in non-Hodgkin's lymphomas.
Chaperot L; Delfau-Larue MH; Jacob MC; Molens JP; Roussel B; Agrawal S; Farcet JP; Gressin R; Sotto JJ; Bensa JC; Plumas J
Exp Hematol; 1999 Jul; 27(7):1185-93. PubMed ID: 10390194
[TBL] [Abstract][Full Text] [Related]
18. CD80 (B7.1) is expressed on both malignant B cells and nonmalignant stromal cells in non-Hodgkin lymphoma.
Dakappagari N; Ho SN; Gascoyne RD; Ranuio J; Weng AP; Tangri S
Cytometry B Clin Cytom; 2012 Mar; 82(2):112-9. PubMed ID: 22076940
[TBL] [Abstract][Full Text] [Related]
19. Cellular and molecular basis for the regulation of inflammation by TGF-beta.
Yoshimura A; Wakabayashi Y; Mori T
J Biochem; 2010 Jun; 147(6):781-92. PubMed ID: 20410014
[TBL] [Abstract][Full Text] [Related]
20. Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-β pathway.
Grainger JR; Smith KA; Hewitson JP; McSorley HJ; Harcus Y; Filbey KJ; Finney CA; Greenwood EJ; Knox DP; Wilson MS; Belkaid Y; Rudensky AY; Maizels RM
J Exp Med; 2010 Oct; 207(11):2331-41. PubMed ID: 20876311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
